Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Product Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06489418
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry and Sensitive Skin.

Who this might be right for
Dry SkinSensitive Skin
NovoBliss Research Pvt Ltd 27
Not applicableStudy completedNCT03535649
What this trial is testing

Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

Who this might be right for
Colitis, Ulcerative
Takeda 105
Not applicableStudy completedNCT02866240
What this trial is testing

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Who this might be right for
Refractory Epilepsy
Neuroelectrics Corporation 20
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Early research (Phase 1)Study completedNCT00000849
What this trial is testing

Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT04078126
What this trial is testing

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 35
Early research (Phase 1)Study completedNCT01859455
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

Who this might be right for
HypercholesterolemiaLDL Cholesterol
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT02037204
What this trial is testing

IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.

Who this might be right for
Foreign-Body ReactionInflammationEffusion (L) Knee+1 more
UMC Utrecht 35
Early research (Phase 1)Study completedNCT03252015
What this trial is testing

Multiple Doses of Lasmiditan in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 70
Testing effectiveness (Phase 2)Study completedNCT06204120
What this trial is testing

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery

Who this might be right for
Pain, Postoperative
Luye Pharma Group Ltd. 150
Large-scale testing (Phase 3)Study completedNCT00857220
What this trial is testing

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Who this might be right for
InsomniaAttention Deficit Hyperactivity Disorder
Sumitomo Pharma America, Inc. 304
Early research (Phase 1)Ended earlyNCT02388152
What this trial is testing

Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease

Who this might be right for
Alzheimer Disease
H. Lundbeck A/S 50
Testing effectiveness (Phase 2)Looking for participantsNCT05632380
What this trial is testing

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT03261947
What this trial is testing

Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors

Who this might be right for
Metastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more
Millennium Pharmaceuticals, Inc. 101
Testing effectiveness (Phase 2)Study completedNCT02743949
What this trial is testing

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

Who this might be right for
Gastroesophageal Reflux
Takeda 256
Testing effectiveness (Phase 2)Ended earlyNCT03860155
What this trial is testing

Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure

Who this might be right for
Acute-On-Chronic Liver Failure
RHEACELL GmbH & Co. KG 5
Not applicableStudy completedNCT02825160
What this trial is testing

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Bayer 282
Large-scale testing (Phase 3)WithdrawnNCT03094468
What this trial is testing

Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis

Who this might be right for
Onychomycosis of Toenail
Polichem S.A.
Early research (Phase 1)Study completedNCT05025397
What this trial is testing

Danavorexton in Anesthetized Adults

Who this might be right for
Healthy Volunteers
Takeda 28
Not applicableStudy completedNCT00727610
What this trial is testing

Development of a Screening Strategy for Community-based Adverse Drug Related Events in the Emergency Department

Who this might be right for
Adverse Drug Related Events
University of British Columbia 1,588
Next Page